Dow Up 0.64% Nasdaq Up 0.68%

Insmed Incorporated (INSM)

-NasdaqGS
13.18 Down 0.11(0.83%) Sep 18, 4:00PM EDT
Prev Close:13.29
Open:13.37
Bid:12.50 x 1000
Ask:13.75 x 400
1y Target Est:30.17
Beta:0.21
Next Earnings Date:N/A
Day's Range:13.00 - 13.43
52wk Range:9.00 - 22.29
Volume:432,447
Avg Vol (3m):856,323
Market Cap:517.75M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INSMDown 0.83%517.75M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.86
Quarterly EPS Est (Sep-14) :-0.46
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers a proven a... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback